Short Decsription
Creative Biolabs offers HEK293T-Tg(Human GPR40 Receptor) Division-Arrested Cell which GPR40 receptor stably expressed in HEK293T cells.
Description
HEK293T-Tg(Human GPR40 Receptor) Division-Arrested Cell was engineered to express the receptor human GPR40 (NM_005303). This cell line can be used to study GPR40 receptor function, signaling pathways, and potential therapeutic interventions. Dividing-arrest cells are cells that are normally kept under specific culture conditions or treated with agents that prevent cell division from being held in a non-dividing state. This can be achieved through methods such as serum starvation, chemical inhibitors of cell cycle progression, or genetic modification.
Features
Well-characterized stable cell lines;
for cell-based high-throughput screening;
Low-cost evaluation of stable cell lines or limited quantities of compounds.
Applications
GPR40 receptor function, signaling pathways, and potential therapeutic interventions.
Protein Target
GPCR
Receptor Name
GPR40
Receptor Family
Free Fatty Acid
Species
Human
Parental Cell Line
HEK293T
Transfection
Expression vector containing full-length human GPR40 cDNA (GenBank Accession Number NM_005303) with FLAG tag sequence at N-terminus
Gene
NM_005303
Background
G-protein coupled receptor 40 (GPR40 or FFA1) is specifically expressed in brain and pancreas. In pancreas, abundant GPR40 is localized to insulin-producing beta cells. Long-chain FFAs amplify glucose-stimulated insulin secretion from pancreatic beta cells by activating GPR40, indicating that GPR40 agonists and/or antagonists have potential for the development of new anti-diabetic drugs. GPR40 overexpression in breast cancer cells amplified oleate-induced proliferation, whereas silencing the GPR40 gene decreased it. These results suggest that GPR40 is implicated in the control of breast cancer cell growth by fatty acids and that GPR40 may provide a link between fat and cancer.

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2024 Creative Biolabs. All Rights Reserved.